Diabetes mellitus: Exploring the challenges in the drug development process.
about
Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy.Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients.Effect of cocoyam (Colocasia esculenta), unripe plantain (Musa paradisiaca) or their combination on glycated hemoglobin, lipogenic enzymes, and lipid metabolism of streptozotocin-induced diabetic rats.FDA safety actions for antidiabetic drugs marketed in the US, 1980-2015.
P2860
Diabetes mellitus: Exploring the challenges in the drug development process.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diabetes mellitus: Exploring the challenges in the drug development process.
@en
type
label
Diabetes mellitus: Exploring the challenges in the drug development process.
@en
prefLabel
Diabetes mellitus: Exploring the challenges in the drug development process.
@en
P2860
P356
P1476
Diabetes mellitus: Exploring the challenges in the drug development process.
@en
P2093
Ashis Patnaik
Julius A Vaz
P2860
P304
P356
10.4103/2229-3485.100660
P577
2012-07-01T00:00:00Z